MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates January 28, 2019
BLISS GVS PHARMA Plunges by 5%; BSE 500 Index Down 1.4%
Mon, 28 Jan 02:04 PM
BLISS GVS PHARMA share price has plunged 5% and is presently trading at Rs 158.
Meanwhile, the BSE 500 Index is at 14,290 (down 1.4%).
Among the top losers in the BSE 500 Index today are BLISS GVS PHARMA (down 5.1%) and BAJAJ FINANCE (down 8.1%).
ZEE ENTERTAINMENT (up 12.3%) and ESSEL PROPACK (up 7.5%) are among the top gainers today.
Over the last one year, BLISS GVS PHARMA has moved down from Rs 204 to Rs 158, registering a loss of Rs 45 (down 22.2%)..
The BSE 500 has moved down from 15,514 to 14,290, loss of 1,224 points (down 7.9%) during the last 12 months.
The top gainers among the BSE 500 Index stocks during this same period were VINATI ORG. (up 63.0%), BATA INDIA (up 54.0%) and NESTLE (up 51.4%).
What About the Benchmark Indices?
The BSE Sensex is at 36,124 (down 1.1%). The top gainers among the BSE Sensex stocks today are L&T (up 1.5%). The most traded stocks in the BSE Sensex are L&T and KOTAK MAH. BANK.
In the meantime, NSE Nifty is at 10,804 (down 1.3%). ZEE ENTERTAINMENT (up 13.0%) and BHARTI INFRATEL (up 2.6%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 36,050 to 36,124, registering a gain of 74 points (up -1.2%).
Indian Share Market Update: Top Gainers and Losers
|
| |
Stock Market Updates
Indian Indices Erase Gains; Sensex Ends 52 Points Higher (Today's Market)
Aug 19, 2019 ClosingAfter opening the day higher, Indian share markets witnessed negative trading activity during closing hours and ended their trading session marginally higher.
SUVEN LIFESCIENCES Surges by 5%; BSE HEALTHCARE Index Up 0.6% (Today's Market)
Aug 19, 2019 03:28 PMSUVEN LIFESCIENCES share price has surged by 5% and its current market price is Rs 248. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are SUVEN LIFESCIENCES (up 5.5%) and THYROCARE TECHNOLOGIES (up 5.7%). The top losers are CIPLA (down 0.1%) and GSK PHARMA (down 0.3%).
ADANI TRANSMISSION Surges by 5%; BSE POWER Index Up 0.2% (Today's Market)
Aug 19, 2019 03:26 PMADANI TRANSMISSION share price has surged by 5% and its current market price is Rs 221. The BSE POWER is up by 0.2%. The top gainers in the BSE POWER Index is ADANI TRANSMISSION (up 5.1%). The top losers are SUZLON ENERGY (down 0.5%) and TORRENT POWER LTD (down 1.0%).
BIOCON Plunges by 5%; BSE HEALTHCARE Index Up 0.5% (Today's Market)
Aug 19, 2019 03:06 PMBIOCON share price has plunged by 5% and its current market price is Rs 232. The BSE HEALTHCARE is up by 0.5%. The top gainers in the BSE HEALTHCARE Index are THYROCARE TECHNOLOGIES (up 5.7%) and SUN PHARMA ADV. RES. (up 3.6%). The top losers is BIOCON (down 5.0%).
INOX WIND Plunges by 6%; BSE CAPITAL GOODS Index Up 1.5% (Today's Market)
Aug 19, 2019 02:24 PMINOX WIND share price has plunged by 6% and its current market price is Rs 44. The BSE CAPITAL GOODS is up by 1.5%. The top gainers in the BSE CAPITAL GOODS Index are V GUARD INDUSTRIES (up 2.7%) and HAVELLS IND (up 2.7%). The top losers is INOX WIND (down 6.1%).
IDBI BANK Surges by 11%; BSE BANKEX Index Up 0.7% (Today's Market)
Aug 19, 2019 02:14 PMIDBI BANK share price has surged by 11% and its current market price is Rs 28. The BSE BANKEX is up by 0.7%. The top gainers in the BSE BANKEX Index is IDBI BANK (up 11.3%). The top losers are SBI (down 0.8%) and YES BANK (down 3.0%).
View More Indian Share Market NewsMost Popular
My Top 3 Dividend Millionaire Stocks(Profit Hunter)
Aug 7, 2019As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.
The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)
Aug 8, 2019This debt-free, well-managed company is all set to soar.
This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)
Aug 12, 2019My experience at the recent AGM of this smallcap company which has financials of any FMCG major.
Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)
Aug 9, 2019Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.
Qatar is Rearing Cows...this is Good News for India
Aug 9, 2019Qatar has turned around after the Saudi embargo. This is good news for India.
More|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Plunges by 5%; BSE 500 Index Down 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!